TheProfitWatch

FENC - Fennec Pharmaceuticals Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
7.8 0.06 (0.77%) 0.0 (0.0%) 0.0 (0.0%) -0.06 (-0.76%) --- 0.06 (0.77%) --- ---

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.11
Diluted EPS:
-0.11
Basic P/E:
-71.4545
Diluted P/E:
-71.4545
RSI(14) 1m:
45.45
VWAP:
7.86
RVol:

Events

Period Kind Movement Occurred At

Related News